494. Deputy Michael Cahill asked the Minister for Health to examine documents (details supplied) in relation to children who are suffering with long-Covid; and if she will make a statement on the matter. [48598/26]
Topics / Disease Management
A subject heading for parliamentary questionsDisease Management
241 questions from 71 TDs, between 22 January 2025 and 22 October 2026.
241
questions
239 written, 2 oral
71
TDs have asked
10
parties and groups
Independents counted together
4
departments asked
Questions per month
The record holds no questions for August, when the Dáil does not sit.
Jan 2025Oct 2026
Show as a table
| Month | Questions |
|---|---|
| January 2025 | 1 |
| February 2025 | 4 |
| March 2025 | 21 |
| April 2025 | 4 |
| May 2025 | 29 |
| June 2025 | 9 |
| July 2025 | 6 |
| August 2025 | 0 |
| September 2025 | 4 |
| October 2025 | 33 |
| November 2025 | 16 |
| December 2025 | 5 |
| January 2026 | 4 |
| February 2026 | 3 |
| March 2026 | 16 |
| April 2026 | 24 |
| May 2026 | 28 |
| June 2026 | 10 |
| July 2026 | 13 |
| August 2026 | 0 |
| September 2026 | 7 |
| October 2026 | 4 |
Who asks, by party
The party each TD belonged to on the day, in alphabetical order. Parties differ a lot in size, and members of the Government answer questions rather than ask them, so this shows who raised it, not how much a party cares about it.
The TDs who asked most
Members of the Government answer questions rather than ask them. Each question counts once.
-
40
-
18
-
16
-
14
-
13
-
10
-
7
-
7
Asked of
Debated under the same heading
Debates whose official heading is exactly these words.
The questions
499. Deputy Albert Dolan asked the Minister for Health if she will review the current list of conditions covered under the long-term illness scheme; if consideration is being given to the inclusion of Crohn’s disease and other inflammatory bowel diseases, in light of their chronic and lifelong nature and the ongoing medication requirements associated with their management; and if she will make a statement on the matt…
517. Deputy David Cullinane asked the Minister for Health the estimated cost of implementing the rare disease action plan in full. [48666/26]
213. Deputy John Connolly asked the Minister for Health the services that are available for people diagnosed with dementia or Alzheimer’s disease in the Clifden area; the details of how these services can be accessed; and if she will make a statement on the matter. [44212/26]
2053. Deputy Ken O'Flynn asked the Minister for Health whether the proposed rare disease early-access framework will include formal eligibility criteria, maximum decision timelines, independent clinical oversight arrangements, and national equity safeguards; and if she will make a statement on the matter. [42490/26]
2054. Deputy Ken O'Flynn asked the Minister for Health whether her Department has conducted any estimate of the potential annual cost exposure associated with a rare disease early-access framework; and if she will make a statement on the matter. [42491/26]
2055. Deputy Ken O'Flynn asked the Minister for Health whether any ethical or legal review has been conducted regarding prioritisation criteria within the proposed early-access framework for rare diseases; and if she will make a statement on the matter. [42492/26]
2056. Deputy Ken O'Flynn asked the Minister for Health whether patient registries or national prevalence datasets will form part of the planned rare disease reimbursement reforms; and if she will make a statement on the matter. [42493/26]
2328. Deputy Ken O'Flynn asked the Minister for Health whether any national respiratory disease monitoring, surveillance, forecasting, winter-planning, population-health management or health-service demand forecasting system currently incorporates prescribing, reimbursement or utilisation data held by the Primary Care Reimbursement Service; if so, to identify each such system, the datasets used, the purpose for which…
223. Deputy Shónagh Ní Raghallaigh asked the Minister for Health if genetic testing targeting diagnosis of those types of Ehlers Danlos syndrome identifiable by such tests will become available to the general population under the Rare Diseases Strategy 2025-2030; and if she will make a statement on the matter. [40446/26]
287. Deputy Ruairí Ó Murchú asked the Minister for Health if harm in rare disease pathways has been known at ministerial, departmental, and HSE service level for years; the reason the State has still not fully activated an independent national structure capable of preventing drift, ensuring policy cohesion, and delivering timely intervention instead of prolonged exposure to avoidable deterioration, through numerous d…
1136. Deputy Ken O'Flynn asked the Minister for Health if the HSE maintains a national registry, prevalence estimate or centrally collated dataset for Friedreich's ataxia patients in the State. [38848/26]
1203. Deputy Ken O'Flynn asked the Minister for Health the number of confirmed lyme disease cases recorded annually in the State from 2020 to 2026, in tabular form; and if she will make a statement on the matter. [39047/26]
1204. Deputy Ken O'Flynn asked the Minister for Health if the HSE maintains national clinical guidance for the diagnosis and treatment of lyme disease; if so, when such guidance was last reviewed or updated; and if she will make a statement on the matter. [39048/26]
1205. Deputy Ken O'Flynn asked the Minister for Health the extent general practitioners receive specific training or continuing professional development guidance relating to lyme disease diagnosis, treatment pathways and long-term complications; and if she will make a statement on the matter. [39049/26]
1206. Deputy Ken O'Flynn asked the Minister for Health if her Department or HSE has conducted a review of delayed diagnosis of lyme disease and associated patient outcomes; and if she will make a statement on the matter. [39050/26]
1207. Deputy Ken O'Flynn asked the Minister for Health the number of patients referred annually for specialist assessment relating to neurological complications associated with lyme disease from 2020 to 2026 [39051/26]
1208. Deputy Ken O'Flynn asked the Minister for Health if the HSE maintains a dedicated referral pathway for patients presenting with suspected neurological lyme disease, lyme arthritis or lyme carditis [39052/26]
1209. Deputy Ken O'Flynn asked the Minister for Health the laboratories recognised by the HSE for lyme disease testing; the testing methodologies currently utilised; and if a review of international testing standards has been undertaken since 2020. [39053/26]
1210. Deputy Ken O'Flynn asked the Minister for Health if the Department or HSE has examined international approaches to lyme disease diagnosis, testing and long-term patient management; if so, which jurisdictions were examined; and if she will make a statement on the matter. [39054/26]
1211. Deputy Ken O'Flynn asked the Minister for Health if the HSE collects data on the number of patients presenting with long-term or chronic symptoms following lyme disease infection; and if she will make a statement on the matter. [39055/26]
1212. Deputy Ken O'Flynn asked the Minister for Health the estimated annual expenditure incurred by the HSE in relation to lyme disease diagnosis, treatment and management from 2020 to 2026, in tabular form. [39056/26]
1213. Deputy Ken O'Flynn asked the Minister for Health if a national public awareness campaign relating to tick-borne illnesses and lyme disease has been undertaken since 2020; the associated annual expenditure; and if she will make a statement on the matter. [39057/26]
1214. Deputy Ken O'Flynn asked the Minister for Health if her Department has assessed regional or seasonal trends in lyme disease incidence within the State; and if she will provide details of same. [39058/26]
1215. Deputy Ken O'Flynn asked the Minister for Health if her Department or HSE has engaged with patient advocacy organisations representing persons living with lyme disease since 2020; the groups involved; the dates of engagement; and the outcomes arising from such engagement. [39059/26]